Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands.
Delta Crystallon BV, Leiden, The Netherlands.
Acta Neuropathol Commun. 2015 Dec 22;3:87. doi: 10.1186/s40478-015-0267-2.
The important protective role of small heat-shock proteins (HSPs) in regulating cellular survival and migration, counteracting protein aggregation, preventing apoptosis, and regulating inflammation in the central nervous system is now well-recognized. Yet, their role in the neuroinflammatory disorder multiple sclerosis (MS) is largely undocumented. With the exception of alpha B-crystallin (HSPB5), little is known about the roles of small HSPs in disease.
Here, we examined the expression of four small HSPs during lesion development in MS, focussing on their cellular distribution, and regional differences between white matter (WM) and grey matter (GM). It is well known that MS lesions in these areas differ markedly in their pathology, with substantially more intense blood-brain barrier damage, leukocyte infiltration and microglial activation typifying WM but not GM lesions. We analysed transcript levels and protein distribution profiles for HSPB1, HSPB6, HSPB8 and HSPB11 in MS lesions at different stages, comparing them with normal-appearing brain tissue from MS patients and non-neurological controls. During active stages of demyelination in WM, and especially the centre of chronic active MS lesions, we found significantly increased expression of HSPB1, HSPB6 and HSPB8, but not HSPB11. When induced, small HSPs were exclusively found in astrocytes but not in oligodendrocytes, microglia or neurons. Surprisingly, while the numbers of astrocytes displaying high expression of small HSPs were markedly increased in actively demyelinating lesions in WM, no such induction was observed in GM lesions. This difference was particularly obvious in leukocortical lesions covering both WM and GM areas.
Since induction of small HSPs in astrocytes is apparently a secondary response to damage, their differential expression between WM and GM likely reflects differences in mediators that accompany demyelination in either WM or GM during MS. Our findings also suggest that during MS, cortical structures fail to benefit from the protective actions of small HSPs.
小热休克蛋白(HSPs)在调节细胞存活和迁移、对抗蛋白聚集、防止细胞凋亡和调节中枢神经系统炎症方面的重要保护作用现在已得到广泛认可。然而,它们在神经炎症性疾病多发性硬化症(MS)中的作用在很大程度上尚未得到证实。除了α B-晶体蛋白(HSPB5)外,人们对小 HSP 在疾病中的作用知之甚少。
在这里,我们研究了在 MS 病变发展过程中小 HSPs 的表达情况,重点关注它们的细胞分布以及白质(WM)和灰质(GM)之间的区域差异。众所周知,这些区域的 MS 病变在病理学上有显著差异,WM 病变的血脑屏障损伤、白细胞浸润和小胶质细胞激活明显更为严重,但 GM 病变则没有。我们分析了 HSPB1、HSPB6、HSPB8 和 HSPB11 在 MS 病变不同阶段的转录水平和蛋白分布谱,将其与 MS 患者和非神经科对照者的正常脑组织进行比较。在 WM 脱髓鞘的活跃阶段,特别是在慢性活跃 MS 病变的中心,我们发现 HSPB1、HSPB6 和 HSPB8 的表达显著增加,但 HSPB11 则没有。当诱导时,小 HSP 仅存在于星形胶质细胞中,而不存在于少突胶质细胞、小胶质细胞或神经元中。令人惊讶的是,虽然在 WM 中活跃脱髓鞘病变中显示小 HSP 高表达的星形胶质细胞数量明显增加,但在 GM 病变中未观察到这种诱导。在覆盖 WM 和 GM 区域的白质病变中,这种差异尤为明显。
由于星形胶质细胞中小 HSP 的诱导显然是对损伤的继发反应,因此它们在 WM 和 GM 之间的差异表达可能反映了 MS 中脱髓鞘时伴随 WM 或 GM 发生的介质的差异。我们的研究结果还表明,在 MS 期间,皮质结构无法从小 HSP 的保护作用中受益。